Journal of muscle and joint health (근관절건강학회지)

Korean Society of Muscle and Joint Health (대한근관절건강학회)
권호 표지
DOI QR코드

DOI QR Code

Factors Affecting Bone Mineral Density of the Femur in Parkinson's Disease Patients

파킨슨병 환자의 골밀도 영향요인

  • Received : 2012.11.02
  • Accepted : 2012.12.02
  • Published : 2012.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study is to explore the level of bone mineral densities of the femur neck and to identify factors affecting bone mineral density of the femur in Parkinson's disease (PD) patients. Methods: Participants were 121 PD patients visiting the outpatient clinic of D University Hospital in B City. Bone mineral density was measured at the femur neck by using a dual-energy x-ray absorptiometry. The serum vitamin D level, the amounts of milk intake, caffeine intake, cigaret smoking, and alcohol consumption, and the number of steps taken daily were measured. Past and present disease history, the medication history, and duration of the disease were also collected. The level of disability was obtained by neurologists using the Hoehn and Yahr stage and the Unified Parkinson's Disease Rating Scale. Results: Among PD patients, 57% had osteopenia and 15.7% had osteoporosis. The bone mineral density of the femur was associated with weight, serum vitamin D level, age, and working status. Conclusion: The identification of weight and serum vitamin D level as important predictive factors emphasizes the importance of balanced nutrition for PD patients.

Keywords

References

  1. Allen, S. H. (1994). Exercise considerations for postmenopausal women with osteoporosis. American College of Rheumatology, 7(4), 205-214.
  2. Bezza, A., Ouzzif, Z., Naji, H., Achemlal, L., Mounach, A., Nouijiai, M., et al. (2008). Prevalence and risk factors of osteoporosis in patients with Parkinson's disease. Rheumatology International, 28(12), 1205 -1209. http://dx.doi.org/10.1007/s00296-008-0632-6
  3. Bikle, D. D. (2008). Integrins, insulin like growth factors, and the skeletal response to load. Osteoporosis International, 19(3), 1237-1246. http://dx.doi.org/ 10.1007/s00198-008-0597-z
  4. Bloem, B. R., Grimbergen, Y. A., Cramer, M., Willemsen, M., & Zwinderman, A. H. (2001). Prospective assessment of falls in Parkinson's disease. Journal of Neurology, 248(11), 950-958. https://doi.org/10.1007/s004150170047
  5. Chapuy, M. C., Arlot, M. E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S., et al. (1992). Vitamin $D_{3}$ and calcium to prevent hip fractures in the elderly women. The New England Journal of Medicine, 327, 1637-1642. http://dx.doi.org/10.1056/NEJM199212033272305
  6. Di Monaco, M., Vallero, F., Di Monaco, R., Tappero, R., & Cavanna, A. (2006). Bone mineral density in hip-fracture patients with Parkinson's disease: a case-control study. Archives of Physical Medicine Rehabilitation, 87, 1459-1462. http://dx.doi.org/10.1016/j.apmr.2006.07.265
  7. Evatt, M. L., Delong, M. R., Khazai, N., Rosen, A., Triche, S., & Tangricha, V. (2008). Prevalence of vitamin D insufficiency in patients with Parkinson's disease and Alzheimer disease. Archives of Neurology, 65, 1348-1352. https://doi.org/10.1001/archneur.65.10.1348
  8. Fahn, S., & Elton, R. L. (2000). Unified Parkinson's disease rating scale. In S. Fahn, C. D. Marsden, D. Calne, & M. Goldstein (Ed). Recent developments in Parkinson's disease.(153-163). New York: Macmillan Health Care Information.
  9. Fernandez, M. C., Parisi, M. S., Diaz, S. P., Mastaglia, S. R., Deferrari, J. M., Seijo, M., et al. (2009). A pilot study on the impact of body composition on bone and mineral metabolism in Parkinson's disease. Parkinsonism & Related Disorder, 13, 355-358. http://dx.doi.org/10.1016/j.parkreldis.2006.12.010
  10. Grimbergen, Y. A., Munneke, M., & Bloem, B. R. (2004). Falls in Parkinson's disease. Current Opinion in Neurology, 17(4), 405-415. http://dx.doi.org/10.1097/01.wco.0000137530.68867.93
  11. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17, 427-442. https://doi.org/10.1212/WNL.17.5.427
  12. Invernizzi, M., Carda, S., Viscontini., G. S., & Cisari, C. (2009). Osteoporosis in Parkinson's disease. Parkinsonism & Related Disorders, 15(5), 339-346. http://dx.doi.org/10.1016/j.parkreldis.2009.02.009
  13. Ishizaki, F., Harada, T., Katayama, S., Abe, H., & Nakamura, S. (1993). Relationships between osteopenia and clinical characteristics of Parkinson's disease. Movement Disorder, 8, 507-511. https://doi.org/10.1002/mds.870080416
  14. Johnell, O., Melton, L. J., Atkinson, E. J., O'Fallon, M., Kurland, L. T. (1992). Fracture risk in patient with Parkinsonism: A population-based study in Olmsted county, Minnesota. Age and Ageing, 21(1), 32-38. https://doi.org/10.1093/ageing/21.1.32
  15. Korea Centers for Disease Control and Prevention (2007). Prevalence of Parkinson's disease. Seoul: Author.
  16. Kamanli, A., Ardicoglu, O., Ozgocmen, S., & Yoldas, T. K. (2008). Bone mineral density in patients with Parkinson's disease. Aging Clinical and Experimental Research, 20, 277-289. https://doi.org/10.1007/BF03324774
  17. Lee, S. H. (2008). Hyperhomocysteinemia due to levodopa treatment as a risk factor osteoporosis in patients with Parkinson's disease. Unpublished master thesis, Ulsan University, Ulsan.
  18. Lorefalt, B., Ganowiak, W., Palhagen, S., Toss, G., Unosson, M., & Granerus, A, K. (2004). Factors of importance for weight loss in elderly patients with Parkinson's disease. Acta Neurologica Scandinavica, 110(3), 180-187. http://dx.doi.org/10.1111/j.1600-0404.2004.00307.x
  19. Sato, Y., Kaji, M., Tsuru, T., & Oizumi, K. (2001). Risk factors for hip fracture among elderly patients with Parkinson's disease. Journal of Neurology Science, 182, 89-93. https://doi.org/10.1016/S0022-510X(00)00458-5
  20. Sato, Y., Kikuyama, M., & Oizumi, K. (1997). High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. American Academy Neurology, 49, 1273-1278.
  21. Schneider, J. L., Fink, H. A., Ewing, S. K., Ensrud, K. E., & Cummings, S. R. (2008). The association of Parkinson's disease with bone mineral density and fracture in older women. Osteoporosis International, 19(7), 1093-1097. http://dx.doi.org/10.1007/s00198-008-0583-5
  22. Taggart, H., & Crawford, V. (1995). Reduced bone density of the hip in elderly patients with Parkinson's disease. Age & Ageing, 24(4), 326-328. https://doi.org/10.1093/ageing/24.4.326
  23. Vaserman, N. (2005). Parkinson's disease and osteoporosis. Joint Bone Spine, 72(6), 484-488. http://dx.doi.org/10.1016/j.jbspin.2004.04.012
  24. Wood, B., & Walker, R. (2005). Osteoporosis in Parkinson's disease. Movement Disorders, 20(12), 1636-1640. http://dx.doi.org/10.1002/mds.20643